BNP Paribas Exane analyst Navann Ty upgraded Phibro Animal Health (PAHC) to Neutral from Underperform with a $24 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAHC:
- Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth
- Phibro Animal Health Reports Strong Q3 Results
- Phibro Animal Health price target raised to $21 from $20 at Morgan Stanley
- Phibro Animal Health: Balancing Strong EPS Growth with Cautious Hold Rating Amidst Flat Animal Health Performance
- Phibro Animal Health reports Q3 adjusted EPS 63c, consensus 52c